ATE430163T1 - Kristall - Google Patents

Kristall

Info

Publication number
ATE430163T1
ATE430163T1 AT01923873T AT01923873T ATE430163T1 AT E430163 T1 ATE430163 T1 AT E430163T1 AT 01923873 T AT01923873 T AT 01923873T AT 01923873 T AT01923873 T AT 01923873T AT E430163 T1 ATE430163 T1 AT E430163T1
Authority
AT
Austria
Prior art keywords
lbd
har
ligand binding
hpr
androgen receptor
Prior art date
Application number
AT01923873T
Other languages
English (en)
Inventor
Peter Donner
Ursula Egner
Maria Carrondo
Pedro Matias
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of ATE430163T1 publication Critical patent/ATE430163T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AT01923873T 2000-03-09 2001-03-09 Kristall ATE430163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0005689.5A GB0005689D0 (en) 2000-03-09 2000-03-09 Crystal
PCT/IB2001/000475 WO2001066599A1 (en) 2000-03-09 2001-03-09 Crystal

Publications (1)

Publication Number Publication Date
ATE430163T1 true ATE430163T1 (de) 2009-05-15

Family

ID=9887287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01923873T ATE430163T1 (de) 2000-03-09 2001-03-09 Kristall

Country Status (9)

Country Link
US (1) US20030167999A1 (de)
EP (1) EP1265927B1 (de)
JP (1) JP2003525948A (de)
AT (1) ATE430163T1 (de)
AU (1) AU2001250557A1 (de)
DE (1) DE60138532D1 (de)
ES (1) ES2326516T3 (de)
GB (2) GB0005689D0 (de)
WO (1) WO2001066599A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235367B2 (en) * 2000-07-12 2007-06-26 Genetics Institute, Llc. Method using crystal structure of estrogen receptor-β complex
JP4447826B2 (ja) * 2002-06-03 2010-04-07 武田薬品工業株式会社 変異アンドロゲン受容体、それを発現する癌細胞、それらの作出方法およびそれらの用途
WO2006117592A1 (en) * 2005-04-29 2006-11-09 Inserm Methods of modulating nuclear receptors
PE20190845A1 (es) * 2012-07-27 2019-06-17 Aragon Pharmaceuticals Inc Metodos para determinar resistencia a terapia de receptor de androgeno

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021993A2 (en) * 1995-12-13 1997-06-19 The Regents Of The University Of California Nuclear receptor ligands and ligand binding domains
JP2003511467A (ja) * 1999-10-14 2003-03-25 ブリストル−マイヤーズ スクイブ カンパニー アンドロゲンレセプターリガンド結合ドメインの結晶構造

Also Published As

Publication number Publication date
JP2003525948A (ja) 2003-09-02
WO2001066599A1 (en) 2001-09-13
GB0005689D0 (en) 2000-05-03
EP1265927B1 (de) 2009-04-29
GB0214799D0 (en) 2002-08-07
AU2001250557A1 (en) 2001-09-17
DE60138532D1 (de) 2009-06-10
ES2326516T3 (es) 2009-10-14
EP1265927A1 (de) 2002-12-18
GB2373505A (en) 2002-09-25
US20030167999A1 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
NO20031350D0 (no) Elektromagnetisk resistivitetsinstrument med evne til å se fremover
ATE161582T1 (de) Monoklonale antikörper der maus
BR0009421A (pt) Inibidores de ligação lfa-1 aos icams e uso dos mesmos
Riddell Aid in the 21st Century
ATE430163T1 (de) Kristall
SE9604731D0 (sv) A component of intercellular junctions in the endothelium
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
AMIR et al. Cytotoxic activity of Thymus vulgaris, Achillea millefolium and Thuja orientalison different growing cell lines
IT7809571A0 (it) Veicolo stradale in due parti snodate con articolazione di accoppiamento
JP2000509064A5 (de)
CA2070799A1 (en) Thioxanthenone antitumor agents
Morris Regional Disparities and Policy in Modern Argentina
Plant President's statement
ES1050950U (es) Protector pectoral antihumedad para bebe
Wang et al. Experiments and calculations of the 100 kHz sky-wave
Wilber et al. Crisis in the American Economy
Koh Current Agricultural and Development Situation in Northeast China
Gardner Rulings that do little to illuminate
Moock Panel on the characteristics of women as users of technology
Lubeck UNIVERSITY CITY: A SUBURBAN COMMUNITY'S RESPONSE TO CIVIL RIGHTS, 1959-1970.
Anderson Discussion: changes in marketing
Kwon The Functional Features of the Progressive
Casa-Hatton Allotment Site, Newmarket Road, Cambridge: A Desktop Study
Artachinda Domestic Marketing of Thai Shrimp and Market Potential for Export
Palovics et al. European Agricultural Policy in a Global Aspect with Special Reference to the European CMEA Countries

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties